Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

aTYR PHARMA (ATYR) Assets Average (2019 - 2025)

aTYR PHARMA (ATYR) has disclosed Assets Average for 7 consecutive years, with $99.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average rose 5.95% year-over-year to $99.8 million, compared with a TTM value of $99.8 million through Dec 2025, up 5.95%, and an annual FY2025 reading of $94.9 million, down 12.71% over the prior year.
  • Assets Average was $99.8 million for Q4 2025 at aTYR PHARMA, down from $104.1 million in the prior quarter.
  • Across five years, Assets Average topped out at $134.8 million in Q2 2023 and bottomed at $46.9 million in Q1 2021.
  • Average Assets Average over 5 years is $101.5 million, with a median of $100.1 million recorded in 2022.
  • The sharpest move saw Assets Average soared 197.97% in 2021, then dropped 23.37% in 2024.
  • Year by year, Assets Average stood at $119.7 million in 2021, then decreased by 19.88% to $95.9 million in 2022, then rose by 28.09% to $122.9 million in 2023, then decreased by 23.31% to $94.2 million in 2024, then grew by 5.95% to $99.8 million in 2025.
  • Business Quant data shows Assets Average for ATYR at $99.8 million in Q4 2025, $104.1 million in Q3 2025, and $99.4 million in Q2 2025.